Injection Drug Use and HCV

Injection drug use accounts for most of the incident infections with Hepatitis C virus (HCV) in the United States. HCV infection is a complex and challenging medical condition in injection drug users. Caring for patients who use illicits drugs presents challenges to the health-care world that require cultural competence, patience, and an understanding of the dynamics of substance use and addiction. Many programs and non-profit agencies are successfully integrating HCV care into health-care settings, however, there are still barriers to proper care for those impacted individuals. Join us next Friday, June 7th, 2019 for our webinar ‘Overcoming Barriers To HCV Care for People Who Inject Drugs’; register here at https://bit.ly/2GsfqcN today!

 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Spotlight On

Karam Mounzer, MD

Dr. Mounzer identified two major gaps in the care of patients with HIV/hepatitis C (HCV) co-infection, and the complexity of multidrug-resistant HIV treatment. He is involved with many clinical trials focusing on drug development and better understanding of HIV immunopathogenesis with the Wistar Institute. He is involved in teaching and mentoring.

Learn More about Spotlight On
Dr. Karam Mounzer

Dr. Mario Cruz

Dr. Mario CruzDr. Cruz is a board certified pediatrician who joins Philadelphia FIGHT as the Medical Director for our Pediatrics and Adolescent Health Center. He completed his undergraduate training in Biology and Psychology from Union College, his medical school training at Albany Medical College, his residency training at St. Christopher’s Hospital for Children, and his Chief Residency at the Albert Einstein Medical Center.


Translate »